Now showing items 1-2 of 2

  • Antiplatelet therapy for atherothrombotic disease in 2022 : from population to patient-centered approaches 

    Jourdi, Georges; Godier, Anne; Lordkipanidzé, Marie; Marquis-Gravel, Guillaume; Gaussem, Pascale (Frontiers Media, 2022-01-28)
    Antiplatelet agents, with aspirin and P2Y12 receptor antagonists as major key molecules, are currently the cornerstone of pharmacological treatment of atherothrombotic events including a variety of cardio- and cerebro-vascular as well as peripheral ...
  • Current and novel antiplatelet therapies for the treatment of cardiovascular diseases 

    Jourdi, Georges; Lordkipanidzé, Marie; Philippe, Aurélien; Bachelot-Loza, Christilla; Gaussem, Pascale (MDPI, 2021-12-03)
    Over the last decades, antiplatelet agents, mainly aspirin and P2Y12 receptor antagonists, have significantly reduced morbidity and mortality associated with arterial thrombosis. Their pharmacological characteristics, including pharmacokinetic/pharmacodynamics ...